Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Sep 26, 2019
Date Accepted: Oct 26, 2019

The final, peer-reviewed published version of this preprint can be found here:

The Use of Web-Based Support Groups Versus Usual Quit-Smoking Care for Men and Women Aged 21-59 Years: Protocol for a Randomized Controlled Trial

Pechmann C, Delucchi K, Calder D, Phillips C, Prochaska JJ

The Use of Web-Based Support Groups Versus Usual Quit-Smoking Care for Men and Women Aged 21-59 Years: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2020;9(1):e16417

DOI: 10.2196/16417

PMID: 31934869

PMCID: 6996731

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Co-ed and women-only Twitter support groups verses usual care to quit smoking: A randomized controlled trial

  • Cornelia Pechmann; 
  • Kevin Delucchi; 
  • Douglas Calder; 
  • Connor Phillips; 
  • Judith J. Prochaska

ABSTRACT

Background:

Existing smoking cessation treatments are challenged by low engagement and high relapse rates, suggesting the need for more innovative, accessible and interactive treatment strategies. Twitter is a mobile platform that allows people to communicate with each other throughout the day right from their phone.

Objective:

This study aims to leverage the social media platform of Twitter for fostering peer-to-peer support to decrease relapse with quitting smoking. Further, the study will compare the effects of co-ed versus women-only groups on women’s success with quitting smoking.

Methods:

The study design is a 3-arm randomized controlled trial with two treatment arms (co-ed or women-only Twitter support group) and a control arm. All participants receive 8 weeks of combination nicotine replacement therapy (patches plus gum or lozenges); serial emails with links to Smokefree.gov quit guides; and encouragement to set a quit date a week into study start. Participants randomized to a treatment arm are placed in a Twitter support group (co-ed or women-only), paired with a buddy (matched on age, gender, location, and education), and encouraged to communicate with the group via daily discussion topics and feedback texts on their tweeting behavior. Recruited online from across the continental United States, the sample is 215 men and 745 women current cigarette smokers wanting to quit, between the ages of 21-59.

Results:

Follow-up surveys are completed at 1, 3, and 6 months post-quit date with cotinine validation at 3- and 6-months. The primary outcome is sustained biochemically-confirmed abstinence at 6-months follow-up.

Conclusions:

This study combines the mobile platform of Twitter with a support group for quitting smoking. Findings will inform the efficacy of virtual peer-to-peer support groups for quitting smoking and potentially elucidate gender differences in quit rates found in prior research. Clinical Trial: ClinicalTrial.gov Registration # NCT02823028 (Last Updated January 2019).


 Citation

Please cite as:

Pechmann C, Delucchi K, Calder D, Phillips C, Prochaska JJ

The Use of Web-Based Support Groups Versus Usual Quit-Smoking Care for Men and Women Aged 21-59 Years: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2020;9(1):e16417

DOI: 10.2196/16417

PMID: 31934869

PMCID: 6996731

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.